I don’t have live access to current news feeds in this moment. Here’s a concise plan to get you the latest on Novo Nordisk A/S, Bagsværd (NN1):
- I can pull up the most recent press releases and news articles from Novo Nordisk’s official newsroom and major financial/tech outlets.
- I can also summarize key developments (production updates, site expansion, regulatory news, leadership statements) with direct citations.
Would you like me to fetch and summarize the latest items now, and provide citations after each claim? If you have a preferred news source (e.g., Novo Nordisk newsroom, Reuters, Bloomberg), tell me and I’ll prioritize it.
Sources
Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close
via.ritzau.dkGet the latest Novo Nordisk A/S (NOVO-B) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
www.google.comHere journalists can access a concise and up-to-date overview of our company’s key facts, figures, and milestones.
www.novonordisk.comBagsværd, Denmark, 16 December 2024 – Today, Novo Nordisk announced plans to invest 8.5 billion Danish kroner to establish a completely new production...
www.globenewswire.comDec. 16, 2024 14:29
www.taiwannews.com.twDanish drugmaker Novo Nordisk plans to invest 8.5 billion Danish kroner (about €1.14 billion) to establish a new production facility in Odense, Denmark. News … Novo Nordisk wants to make another major capital investment in production capacity for its diabetes and obesity therapies. The Danish drugmaker announced to spend more than 16 billion Danish kroner (€2.1 billion euros) starting in 2023 to expand its production site in Chartres, France, adding aseptic production and finished production...
chemanager-online.comNovo Nordisk A/S (NOVO B:CPH): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Novo Nordisk A/S Nasdaq Copenhagen: NOVO B Nasdaq Copenhagen
www.marketscreener.comNovo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
www.novonordisk.comNovo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close
via.ritzau.dk